Explore the Agenda

8:00 am Check In & Light Breakfast

Workshop A

9:00 am Optimizing & Automating Sample Processing & Working Effectively With Challenging Samples to Enable Scalable, High Throughput Proteomics Across Drug Discovery Pipelines

Associate Director, Genomic Medicine & Bioanalytics Characterization, Sanofi
Associate Principal Scientist, AstraZeneca

Proteomics analysis is driven by sensitive and fast instrumentation, but sample preparation remains a critical bottleneck, especially when working with limited or low-quality data. To fully realize the potential of scalable proteomics for drug discovery, it's crucial that sample preparation workflows are accelerated and optimized.

This workshop will gather experts to discuss how to:

  • Transition to scalable, automated sample processing with plate-based formats, minimizing hands-on steps, accounting for variation in sample collection, and adopting automation tools
  • Overcome poor sample quality with optimized protocols for low-abundance samples, effective enrichment strategies, and methods to reduce protein loss during preparation
  • Uphold quality control standards during assay development, sample collection, processing, and storage to maintain sample integrity and facilitate reproducible proteomics analysis

12:00 pm Lunch Break & Networking

Workshop B

1:00 pm Implementing Multi-Omics Into Drug Discovery Workflows to Paint a Holistic Picture of Health, Contextualize Proteomics Insights & Make Well-Informed Drug Discovery Decisions

Senior Director, Head of Discovery Science, Cellarity
Vice President, Proteomics Discovery, RyboDyn

Whilst proteomics has the potential to reveal the workings of the proteome and 

demystify disease signalling pathways, part of the story is still missing. Combining 

genomics, transcriptomics, and metabolomics insights to contextualize proteomics is 

vital to better understand pathology and guide therapeutic discovery.

This workshop will gather experts to discuss how to:

  • Effectively harmonize and integrate genomics, transcriptomics, and metabolomics data to bolster understanding of proteomics and generate a more holistic view of pathology and therapeutic response 
  • Employ innovative computational and AI tools to streamline multi-omics workflows and maximize time and cost-efficiency of large-scale data analysis
  • Apply multi-omics across drug discovery, from deconvoluting disease pathways and identifying novel targets to validating biomarkers and optimizing hit identification 

4:00 pm End Pre-Conference Workshop Day